Agenda | MedTech World Middle East

A high-level address from a senior UAE or GCC government health authority setting the tone for where the region stands today — and what the next five years require from MedTech innovators and investors alike.

The HealthTech investment landscape has shifted as sovereign wealth funds, family offices, and international VCs pivot toward the Middle East. This panel examines where capital is moving, what makes founders fundable today, and debates deal structures, due diligence realities, and untapped opportunities across Saudi Arabia, UAE, and beyond.

AI, automation, and connected technologies are turning the smart hospital concept into reality through interoperable infrastructure, intelligent workflows, robotics, and predictive operations. This panel explores the foundations of smart hospitals, the role of AI and cybersecurity, implementation challenges, and the investment needed to scale these systems sustainably.

Diabetes, obesity, and cardiometabolic disease remain urgent regional and global health challenges, pushing systems toward earlier detection, continuous monitoring, digital therapeutics, and AI enabled risk prediction. This panel covers next generation diagnostics, wearables, obesity management, and integrated chronic care, exploring how MedTech, pharma, and providers can improve outcomes and reduce long-term costs.

The GCC is becoming both a high growth market and a launchpad for international expansion, while regional startups seek pathways to scale into Europe, the U.S., and Asia. This panel explores market entry strategy, regulation, reimbursement, partnerships, and localization, examining how companies move from pilot to adoption and how the GCC bridges regional innovation with global commercialization.

Initiatives like Riayati, Malaffi, and NABIDH are driving connected care and AI adoption across healthcare systems. Industry leaders discuss interoperability, cybersecurity, cloud infrastructure, digital twins, and real world data as building blocks for smart hospitals, exploring how governments, providers, and tech companies can create healthcare’s digital backbone together.

Medical tourism is entering a new era shaped by digital health, AI, precision medicine, and seamless patient experiences, as the GCC positions itself as a global destination for specialized care. This panel covers AI diagnostics, virtual consultations, robotics, and digital patient journeys, and how hospitals, governments, and investors are building technology enabled, internationally connected care pathways.

Regulatory shifts, tighter capital, longer sales cycles, and proving clinical validity without clinical data make MedTech building harder than ever. This honest panel gathers founders, operators, and investors to discuss real challenges: hiring, burn rate management, clinical trial design on limited budgets, and finding hospital partners willing to co-develop, not just evaluate.

How do great HealthTech companies go from idea to global scale? This panel will explore the role of accelerators, incubators, innovation hubs, corporate venture programs, and investors in helping founders validate technology, navigate regulation, secure funding, and achieve commercial success.

Saudi Arabia’s National Biotechnology Strategy 2040 is moving into execution, anchored by a new BioLabs Biotech Accelerator, an eight company first cohort, and $50M commitments each from IB Ventures and Sarat Ventures. The panel unpacks vaccine sovereignty, CDMO capacity, cell and gene therapy manufacturing, and how global biotech firms can engage this emerging ecosystem.

Women’s health remains historically underserved in global clinical research, with MENA facing added gaps from cultural context, distinct disease patterns, and access barriers. FemTech innovators, clinicians, and investors join to discuss purpose built technologies, the developing evidence base, and how regional health systems are integrating maternal health, menopause care, and reproductive health platforms.

Mental health has entered GCC health policy, but scalable, clinically validated digital solutions still lag behind awareness efforts. This panel covers the evidence base for digital therapeutics, cultural and linguistic adaptation for MENA populations, employer facing workplace platforms, and how VR, AI driven CBT tools, and telepsychiatry are being adopted regionally.

Surgical innovation, robotics, AI imaging, intraoperative navigation, and AR overlays, is spreading from academic centres to community hospitals. This panel debates which technologies are genuinely deployment ready, what training and credentialing frameworks are needed, and how the Middle East is positioning itself as a hub for next generation surgical care.

The GCC is becoming a major healthcare investment market, driven by government initiatives and rising private capital, with investors now prioritizing commercial traction and regulatory strategy over technology alone. This panel explores where capital is flowing, valuation trends, cross border opportunities, and the GCC’s shift from investment destination to innovation source.

The GCC pharma market, already over $30 billion and heading toward $45 billion by 2030, is shifting from importer to producer through sovereign investment in biomanufacturing, vaccine localisation, and CDMO capacity. Examples like Mubadala Bio, Julphar, and Lifera CDMO frame a panel on what this means for global pharma partnerships and procurement.